effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial)
Open Access
- 25 August 2002
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 40 (4) , 662-668
- https://doi.org/10.1016/s0735-1097(02)02014-4
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor TirofibanNew England Journal of Medicine, 2001
- Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trialThe Lancet, 2001
- Minimal myocardial damage during coronary intervention is associated with impaired outcomeEuropean Heart Journal, 1999
- Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous interventionJournal of the American College of Cardiology, 1999
- Myocardial damage during percutaneous transluminal coronary angioplasty as evidenced by troponin T measurementsEuropean Heart Journal, 1998
- Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial IschemiaNew England Journal of Medicine, 1996
- Troponin T, troponin I and creatine kinase-MB mass after elective coronary stentingCoronary Artery Disease, 1996
- Significance of cardiac troponin T release after percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1995
- Masking of heparin activity in the activated coagulation time (ACT) by platelet procoagulant activityThrombosis Research, 1994
- Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectorisAmerican Heart Journal, 1994